An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,616 | 82,519 | 12,097 | 0 | 0 |
| Marketable Securities | 72,773 | 35,835 | 46,458 | 0 | 0 |
| Other current assets | 13 | 32 | 0 | 0 | 0 |
| TOTAL | $116,877 | $119,783 | $60,106 | $0 | $0 |
| Non-Current Assets | |||||
| Investments And Advances | 2,419 | 0 | 3,486 | 0 | 0 |
| Other Non-Current Assets | 720 | 720 | 1,724 | 0 | 0 |
| TOTAL | $3,139 | $720 | $5,210 | $N/A | $N/A |
| Total Assets | $120,016 | $120,503 | $65,316 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,612 | 2,609 | 1,063 | 0 | 0 |
| Accrued Expenses | 2,515 | 2,436 | 2,315 | 0 | 0 |
| Other current liabilities | 9 | 10 | 17 | 0 | 0 |
| TOTAL | $4,149 | $5,087 | $3,395 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4 | 6 | 13 | 0 | 0 |
| TOTAL | $4 | $6 | $13 | $N/A | $N/A |
| Total Liabilities | $4,153 | $5,093 | $3,408 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,403 | 19,403 | N/A | N/A | N/A |
| Retained earnings | -66,542 | -56,422 | -47,384 | 0 | 0 |
| Other shareholders' equity | -360 | -158 | 109,292 | 0 | 0 |
| TOTAL | $115,863 | $115,410 | $61,908 | $0 | $0 |
| Total Liabilities And Equity | $120,016 | $120,503 | $65,316 | $0 | $0 |